SUSAN ADE: Open Payments
NPI 1447447008 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 51 payments from 12 companies in 2025. Trend: 2023 $417 · 2024 $989 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $266 |
| GlaxoSmithKline, LLC. | 13 | $249 |
| Lilly USA, LLC | 7 | $147 |
| Eisai Inc. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: TRELEGY ELLIPTA, VRAYLAR, MOUNJARO, QULIPTA, Leqembi, XIFAXAN, JARDIANCE, GEMTESA.
Industry payments across CT — which companies pay providers there.
